OPTN Archived Articles
OptiNose: Navigating the Chronic Sinusitis Opportunity with Specialty Focus
Published on March 08, 2025
OptiNose, Inc. (NASDAQ:OPTN): Significant Opportunity Ahead with Chronic Sinusitis Approval
Published on September 24, 2024